SEC Form 4 · accession 0001179110-16-021314
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Bernard O'Connor
Officer — Chief Financial Officer
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2016 | S | 3,330 | $35.00 | D | 25,011 | D | |
| Common StockF1,F2 | Mar 4, 2016 | S | 5,287 | $34.01 | D | 19,724 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $33.75 to a high of $34.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.